Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6SYNDAX

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 11479557

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4327

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-08

blank

02

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 11479557

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4045

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-08

blank

03

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 11479557

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4045

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-08

blank

04

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 11479557

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4327

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-08

blank

05

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 11479557

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4327

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-08

blank

06

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 11479557

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4045

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-08

blank